Kuo-chin T. Chang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: July 22, 2025
Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: April 23, 2025
A long term bone and renal safety of TAF treatment on renal transplant recipients.
Journal: Biomedical journal
Published: August 14, 2024
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation.
Journal: Journal of infection and public health
Published: March 09, 2023
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral.
Journal: Viruses
Published: November 03, 2022
Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 19, 2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.
Journal: Digestive diseases and sciences
Published: December 20, 2021
Significant association between serum Wisteria floribunda agglutinin-positive Mac-2-binding protein and prognosis of hepatocellular carcinoma after surgical treatment.
Journal: American journal of cancer research
Published: October 19, 2021
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 08, 2021
A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir.
Journal: Hepatology international
Published: October 27, 2020
Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction.
Journal: International journal of clinical practice
Published: June 18, 2020
Last Updated: 09/26/2026